Compliance-Ready Mass Spectrometry for Bio/Pharmaceutical Analysis and Development
Sign up for this exclusive content from LCGC and get notified when additional information on this topic becomes available.
Untitled Document
Examine real-use cases of how a networked Chromatography Data System is the best choice for data acquisition and processing for quantitative LC-MS analyses and for ensuring business efficiency, regulatory compliance and data integrity.
This eBook covers:
Update on chromatography and data integrity including discussions on why a networked CDS ensures efficiency and regulatory compliance
Increasing throughput of native SEC-MS in biopharmaceutical development using a tandem UHPLC setup
How Pfizer is building the Multi-Attribute Method (MAM) lab-of-the-future by deploying MAM across their various sites
Biosimilar sequence variant assessment and product quality attribute monitoring